Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Email me when S 4512 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 4512. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill forces private health plans to limit out‑of‑pocket costs for a 30‑day supply of insulin to $35 or 25 % of the plan’s negotiated price, whichever is lower, beginning in 2027. It also creates a HHS program that pays pharmacies or providers the gap between an uninsured person’s cost and $35, so uninsured patients pay at most $35. The aim is to make insulin affordable for both insured and uninsured Americans.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 4512
3 free questions a day, no accountSponsors
- Sen. Kennedy, John [R-LA] (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 4512 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 4512 freeOr ask your AI assistant about S 4512 directly:
Add to Claude, ChatGPT or Cursor